44
Complex medication challenges : Where to start Louise Mallet Louise Mallet, B.Sc.Pharm., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne en gériatrie, Centre universitaire de santé McGill Professeure titulaire de clinique Faculté de pharmacie, Université de Montréal

Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Complex medication challenges : Where to start

Louise Mallet Louise Mallet, B.Sc.Pharm., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C.

Pharmacienne en gériatrie, Centre universitaire de santé McGill

Professeure titulaire de clinique

Faculté de pharmacie, Université de Montréal

Page 2: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Conflict of interest

• I have no conflict of interest to declare

2019-12-03 2McGill Annual Refresher Course

Page 3: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Objectives

1. Understand what is a complex patient;

2. Deprescribe drugs safely in elderly patients;

3. Apply a systematic approach in reviewing medications including: preference of the patient frailty scale, therapeutic objectives, life expectancy, time to have an effect and evaluation of the medications.

2019-12-03 3McGill Annual Refresher Course

Page 4: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

« This is a complex patient »

• What is a complex patient?

• Your definition

2019-12-03 4McGill Annual Refresher Course

Page 5: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Complex care needs

• Multiple chronic conditions

• Medication-related problems

• Mental health issues

• Social vulnerability

2019-12-03 5

Pluye P et al. Characteristics of complex care needs and interventions suited for patients with such needs: A participatory scoping review. http://reseau1quebec.ca/wpcontent/uploads/2014/06/McGill_PBRN_Reseau-1_posters.pdf

McGill Annual Refresher Course

Page 6: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 6McGill Annual Refresher Course

Page 7: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 7McGill Annual Refresher Course

Page 8: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

St Sauver JL et al. BMJ Open 2015

Payne RA et al. Neur J Clin Pharmacol2014

DEMULTIPLESCOMORBIDITÉS

PourlesquellessontprescritsDEMULTIPLEMÉDICAMENTS

LESCONSÉQUENCES

Boyd CM et al. JAMA 2005

PATIENTSÂGÉSETPOLYPHARMACIE

InsuffisancerénaleHypotensionorthostatique

ErreursMédicamenteusesEffetsindésirables

ChutesConfusion-delirium

Hospitalisations

ADHÉSIONAUXMÉDICAMENTS???

Interactionsmédicament-médicamentInteractionsmédicament-comorbidités

Décès

Hémorragies

Visiteurgence

Effetsindésirablesdesmédicaments

PRESCRIPTIONSPOTENTIELLEMENTINAPPROPRIÉES

Syndromesgériatriques-médicament

CASCADEMÉDICAMENTEUSE

Steinman MA. JAMA 2016

CHARGEANTICHOLINERGIQUEDOSENONAJUSTÉESELONLAFONCTIONRÉNALEOULEPOIDS

2019-12-03 8Adapté de: https://slideplayer.fr/slide/12363028/LangMcGill Annual Refresher Course

Page 9: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 9McGill Annual Refresher Course

Page 10: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

M. Giroux

M. Giroux, 90 years old, lives alone in his apartment . Today he presents withconfusion and falls . His daughter says that he had 2 falls in the past 2 weeks and she notices that he is more confused today.

Daughter visits 3 times a week and helps with meals. His wife died 5 years ago.

Has a cane, CLSC 1 x/week for shower, decrease appetite as per daughter

PMH: Diabetes, hypertension, hypothyroidism, leg pain, depression, constipation, insomnia

NKDA, one glass of wine a week, ex-smoker

2019-12-03 10McGill Annual Refresher Course

Page 11: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Medications

Delivered in vials

Take his own medications.

Does not know the name of his medications but knows the reasons. He says he takes too many medications.

His daughter sayts that she often finds some medications on the floor when she visits.

2019-12-03 11McGill Annual Refresher Course

Page 12: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Name Posologie Reason

ECASA 80 mg 1 tab po 1 x/day ??

Sitagliptine 50 mg /Metformin 1 gm

1 tab po 2 x/day Diabetes

Glyburide 5 mg 1 tab po daily prn Diabetes

Telmisartan 80 mg + HCTZ 12,5 mg

1 tab po 1 x/day Hypertension

Atorvastatin 40 mg 1 tab po 1 x/day Cholesterol

Levothyroxine 0.075 mg 1 tab po 1 x/day Hypothyroidism

Pantoprazole 40 mg 1 tab po 1 x/day ?? GI protection on ASA

Citalopram 20 mg 1 tab po 1x/day Dépression

Acetaminophen 500 mg 1 tab po 4 x/day Leg pain

Acetaminophen 500 mg /Methocarbamol 500 mg

1 tab po q 4-6 hrs prn Leg pain : took 4 tabs/day for past4 days

Lorazepam 1 mg 1 tab po q hs regular Insomnia

Colace 100 mg 1 cap po 2 x/d Constipation

Lax-a-day 17 gm 17 gm po daily Constipation2019-12-03 12McGill Annual Refresher Course

Page 13: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 13McGill Annual Refresher Course

Time Monday Tuesday Wednesday Thursday Friday Saturday Sunday 8h00 ECASA

Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

ECASA Sitagliptin Metformin Glyburide prn Telmisartan HCTZ Colace Acetaminophen Acetaminophen +Methocarbamol

12h00 Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

Levothyroxine Acetaminophen Acetaminophen +Methocarbamol

17h00 Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

Sitagliptin Metformin Acetaminophen Pantoprazole Atorvastatin Colace Lax-a-day Acetaminophen +Methocarbamol

22h00 Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Acetaminophen Citalopram Lorazapem Acetaminophen +Methocarbamol

Total # of medications/day : 16 Total # of doses/day : 28

Page 14: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 14McGill Annual Refresher Course

Page 15: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Number of medications and adverse drug reactions

0

1

2

3

4

5

6

7

Mortality Falls Disability FrailtyMORTALITÉ CHUTESINVALIDITÉ FRAGILITÉ

2019-12-03Gnjidic D et al. Polypharmacy cutoff and outcomes. J Clin Epidemiol 2012;65:989-995

1 705 men living at home, 70 to 97

years of age

Num

ber o

f M

edic

atio

ns

Type of ADR

5

Utilisé avec permissionC.Tannenbaum

15McGill Annual Refresher Course

Page 16: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Number of medications and risk of hospitalisation associated with medications

12 Adverse Drug Reaction�Related Hospitalizations Among Seniors, 2006 to 2011

Figure 2: Percentage of Seniors on Public Drug Programs Hospitalized for an ADR, by Number of Drugs, Selected Provinces,* 2010�2011

Note * The three provinces submitting linkable data to the DAD and the NPDUIS Database as of July 2012: Alberta,

Manitoba and Prince Edward Island. Sources National Prescription Drug Utilization Information System Database, Discharge Abstract Database and Hospital Morbidity Database, Canadian Institute for Health Information.

It is sometimes necessary for seniors, particularly those with multiple chronic conditions, to take multiple drugs to manage their conditions. The use of a higher number of drugs is associated with a higher risk of ADRs and other adverse events such as drug interactions.38�40 Regular reviews of patients� medications by their physicians and pharmacists can help reduce these risks.41 Medication reconciliation, a process where medications are systematically reviewed at care transition points (for example, when a patient is admitted to hospital) can also help reduce the risk of ADRs by ensuring that any changes in medication that occur at these points are assessed and documented.42

The effectiveness of any medication review is limited by the information available to the person conducting it.43, 44 It is important for patients, where possible, to inform their physicians and pharmacists of all drugs they are taking, including those prescribed by other physicians or obtained over the counter (that is, without a prescription). The implementation of drug information systems, a key component of the electronic health record, has been at least partially completed in several provinces to date.45 These systems will provide access to more complete information on patients� medications.45

2019-12-03

Canadian Institute of Health Information. Adverse drug reaction-related hospitalizations among seniors, 2006-2011. March 2013

Number of medications

Prop

ortio

n of

hos

pita

lized

geria

tric

patie

nts

follo

win

gan

adv

erse

dru

gre

actio

n(%

)

OR 2,0(95 % IC 1,7-

2,2)

OR 3,8(95 % IC 3,3-4,2)

OR 6,4(95 % IC 5,6-7,3)

<5 5-9 10-14 15+

Utilisé avec permissionC.Tannenbaum

16McGill Annual Refresher Course

Page 17: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

• Serum Creatinine = 130 umol/l (stable)

• Weight : 70 kg (Lost 2,5 kg in past 2 months) Height : 1,70 m

• Na 135 mmol/L; K 4,2 mmol/L; TSH 10 m/UI

• ClCr = 40 ml/min

• HbA1c 7,1 %

• Blood glucose at home: This week between 4 et 7 mmol/l (according to hisdaughter)

• Blood pressure : 116/73 mm Hg; 113/84 mm Hg, 120/60 mm Hg

2019-12-03 17

Lab Tests

McGill Annual Refresher Course

Page 18: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

« How do we start »?

2019-12-03 18McGill Annual Refresher Course

Page 19: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Match medical problems and medicationsMedicalproblems

Medications

FallsOrthostatic hypotension(Geriatric syndrome)

Citalopram 20 mg 1x/dSitagliptin/Metformin (50 mg/1000 mg) 1 CO BID Glyburide 5 mg 1x/d prnTelmisartan 80 mg + HCTZ 12,5 mg 1x/dPantoprazole 40 mg 1x/d Atorvastatin 40 mg 1x/d Lorazepam 1 mg qhs regularAcétaminophen/Méthocarbamol (500 mg/400 mg) 1 CO q4-6H PRN (took 4 x/d x 4 days regular

Confusion(Geriatric syndrome)

Citalopram 20 mg 1x/j Glyburide 5 mg 1x/j prnLorazepam / mg 1 CO at bedtimeAcetaminophen/Methocarbamol (500 mg/400 mg) 1 CO q4-6H PRN Sitagliptin/Metformin (50 mg/1000 mg) 1 CO BID Glyburide 5 mg 1x/j prn

Diabetes Sitagliptin/Metformin (50 mg/1000 mg) 1 CO BID Glyburide 5 mg 1x/d prn

Hypertension Telmisartan 80 mg + HCTZ 12,5 mg 1x/d

Cholesterol Atorvastatine 40 mg 1x/d

Hypothyroidism Levothyroxine 0,075 mg 1x/j

Depression Citalopram 20 mg 1x/j

Leg pain Atorvastatine 40 mg 1x/j

Insomnia Lorazepam 1 mg 1 x/at bedtime

Constipation Colace 100 mg 1cap 2 x/j Lax-a-day 17 g po daily

Other problems ? ASA, ? Pantoprazole

2019-12-03 19McGill Annual Refresher Course

Page 20: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 20McGill Annual Refresher Course

Page 21: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 21https://www.dal.ca/site/gmr/our-tools/clinical-frailty-scale.html

McGill Annual Refresher Course

Page 22: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Is Mr. Giroux

1. Fit

2. Vulnerable

3. Frail

2019-12-03 22McGill Annual Refresher Course

Page 23: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Copyright restrictions may apply.

Holmes, H. M. et al. Arch Intern Med 2006;166:605-609.

Upper, middle, and lower quartiles for life expectancies for women (A) and men (B) on the basis of the US life tables

Femmes

Hommes

2019-12-03 23McGill Annual Refresher Course

Page 24: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Remaining number of years of life accordingto age and functional status

Men

18

14,2

10,8

7,9

5,8

12,4

9,3

6,7

4,7

3,2

6,7

4,9

3,32,2

1,5

70 ans 75 ans 80 ans 85 ans 90 ans

Walter & Covinsky 2001

2019-12-03 24

Adapted from : https://slideplayer.fr/slide/12363028/Lang

Green: Fit Red: Vulnerable Orange: Frail

McGill Annual Refresher Course

Page 25: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 25

Meneilly G, et coll Can J Diabetes 2018;42:S283-95McGill Annual Refresher Course

Page 26: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03

Meneilly G, et coll Can J Diabetes 2018;42:S283-95

26McGill Annual Refresher Course

Page 27: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

• Frail elderly• HbA1c = 7,1 %;• Preprandial glucose: between 4 and 10 mmol/L• Blood pressure: 116/93 mm Hg; 123/84 mm Hg,

120/60 mm Hg (? 0rthostatic hypotension)• Patient is confused, had 2 falls

2019-12-03

What would be the therapeuticobjectives for M. Giroux

Diabetes and Hypertension

27McGill Annual Refresher Course

Page 28: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

• HbA1c <8,5%;

• Preprandial glucose: 6-9 mmol/L

• Postprandial glucose: <14 mmol/L

• Blood pressure: <150/90 without orthostatichypotension

2019-12-03

Therapeutic objectivesFor M. Giroux

28McGill Annual Refresher Course

Page 29: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Drug 1 Side effect Drug 2 Side effect

Medication cascade

2019-12-03 29McGill Annual Refresher Course

Page 30: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Medication cascade

2019-12-03 30McGill Annual Refresher Course

Page 31: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Atorvastatin Legpain Methocarbamol

Anticholinergic-confusion

Potential medication cascade for M. Giroux

2019-12-03 31McGill Annual Refresher Course

Page 32: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 32

Beers Criteria 2019. J Am Ger Society 2019;67:674–694.

Attention: Cyclobenzaprine (Flexeril)

McGill Annual Refresher Course

Page 33: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Cyclobenzaprine(Flexeril)

• Structure reliée à

2019-12-03 33

Chemical structure related to Amitriptyline

McGill Annual Refresher Course

Page 34: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

http://www.anticholinergicscales.es/

2019-12-03 34

Drug Burden Index

McGill Annual Refresher Course

Page 35: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03

Automatic renewal

35McGill Annual Refresher Course

Page 36: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

2019-12-03 36McGill Annual Refresher Course

Page 37: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Match medications

Medicalproblems55

Medications Therapeuticobjectives

Solution

Falls Citalopram 20 mg 1x/dSitagliptin/Metformin(50 mg/1000 mg) 1 CO BIDTelmisartan 80 mg + HCTZ 12,5 mg 1x/j Glyburide 5 mg po 1x/j prnPantoprazole 40 mg 1x/j Atorvastatin 40 mg 1x/j Lorazepam 1 mg q hs

Prevention of falls, fractures

See other problems

Confusion Acétaminophen/Methocarbamol(500 mg/400 mg) 1 CO q4-6H PRNGlyburide 5 mg po 1x/d prnCitalopram 20 mg 1x/dLorazepam 1 mg q hs

Prevent delirium CAMGlucose level

Diabetes Sitagliptin/Metformin(50 mg/1000 mg) 1 CO BIDGlyburide 5 mg po 1x/j prn

Glycémie prépandiale 6 et 9 mmol/LPostprandiale <14 mmol/LHbA1c < 8,5%

CrCl = 40 ml/minStop GlyburideDecrease dose of Sitagliptinto 50 mg dailyMetformin 500 mg po bid

2019-12-03 37McGill Annual Refresher Course

Page 38: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Match medications

Medicalproblems

Medications Therapeuticobjectives

Solution

HTN Telmisartan 80 mg + HCTZ 12,5 mg 1x/j

<150/90 withoutorthostatic hypotension

Discontinue HCTZBP: Lying and standingCould decrease dose of Telmisatan 40 mg po daily

Cholesterol Atorvastatin 40 mg po daily(leg pain)

??? Discontinue atorvastastinDiscontinue Acetaminophen + Methocarbamol

Diabetes Sitagliptin/Metformin(50 mg/1000 mg) 1 CO BIDGlyburide 5 mg po 1x/j prm

Glycémie prépandiale 6 et 9 mmol/LPostprandiale <14 mmol/LHbA1c < 8,5%

CrCl = 40 ml/minStop GlyburideDecrease dose of Sitagliptin to 50 mg dailyMetformin 500 mg po bid

Hypothyroidism

Levothyroxine 0,075 mg po dailyTSH 10 m/UI

TSH 0,5-5,5 m/UI Not compliantKeept same doseRepeat in 6 weeks

? ECASA 80 mg po daily ??? Discontinue

? GI Pantoprazole 40 mg po daily ??? Taper/discontinue

2019-12-03 38McGill Annual Refresher Course

Page 39: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Match medications

Medicalproblems

Medications Therapeuticobjectives

Solution

Depression Citalopram 20 mg po q hs Geriatric DepressionScale

Evaluation GDSCould start tapering

Insomnia Lorazepam 1 mg po qhs Prevention of falls, confusion etc

Discuss with patientStart tapering

Compliance Use of DispillNeed to evaluate

2019-12-03 39McGill Annual Refresher Course

Page 40: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Time Monday Tuesday Wednesday Thursday Friday Saturday Sunday 8h00 ECASA

Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

ECASA Sitagliptin Metformin Telmisartan Acetaminophen Levothyroxine

12h00 Acetaminophen

Acetaminophen

Acetaminophen

Acetaminophen

Acetaminophen

Acetaminophen

Acetaminophen

17h00 Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

Metformin Acetaminophen Lax-a-day

22h00 Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Acetaminophen Citalopram Lorazapem

Total # of medications/day : 9 from 18 Total # of doses/day : 13 from 28

2019-12-03McGill Annual Refresher Course 40

Page 41: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

« Time-to-review expiry date »• « Integrate the culture of deprescribing in the

medical culture when a medication is started

• « Medication prescribe for life: should bereplaced by « Time to review- expiry date

2019-12-03

Reeves E et al. Eur J Inter Med 2017

41McGill Annual Refresher Course

Page 42: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Evaluation of medicationsDefine priorities with patientList the medical problemsEvaluate life expectancyEvaluate if patient is fit, vulnerable or frailDefine the therapeutic objectives for the patient and plan to follow up (efficacy and side effFind the best solution for the patient Plan follow up for effectiveness and safetyDecrease barrier to adherence to treatmentAssure continuity of care: Nurse practitioner, pharmacist

2019-12-03 42McGill Annual Refresher Course

Page 43: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Healthy Aging

2019-12-03 43McGill Annual Refresher Course

Page 44: Complex medication challenges: Where to startComplex medication challenges: Where to start Louise Mallet Louise Mallet, B.Sc.Pharm ., Pharm.D.,BCGP, FESCP, FOPQ, D.H.C. Pharmacienne

Conclusion

[email protected]

2019-12-03 44